# The Liver Has Its Own Pathway for Ozempic. Researchers Just Found It. - Date: 2026-04-14 - Category: Biotech & Life Sciences When researchers removed GLP-1 receptors from a rare liver cell type, semaglutide's liver protection vanished in mice — even with 20% weight loss. This separates the drug's liver benefits from its appetite effects, reshaping how obesity medicines are designed. ---